Amryt announces the appointment of sheila frame as president americas

Dublin, ireland, and boston ma, april 6, 2021, amryt (nasdaq: amyt, aim: amyt), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, is pleased to announce the appointment of sheila frame as president americas. sheila will lead all aspects of product commercialization for amryt in the americas.  sheila has held senior leadership roles across several specialty areas with novartis, bristol-myers squibb, ucb, and astrazeneca and has worked and lived in north america and in europe.  sheila holds an mba from concordia university.
AMYT Ratings Summary
AMYT Quant Ranking